1qbr

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1qbr.gif|left|200px]]
[[Image:1qbr.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1qbr |SIZE=350|CAPTION= <scene name='initialview01'>1qbr</scene>, resolution 1.8&Aring;
+
The line below this paragraph, containing "STRUCTURE_1qbr", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=XV6:[4R-(4ALPHA,5ALPHA,6BETA,7BETA)]-3,3&#39;-[[TETRAHYDRO-5,6-DIHYDROXY-2-OXO-4,7-BIS(PHENYLMETHYL)-1H-1,3-DIAZEPINE-1,3(2H)-DIYL]+BIS(METHYLENE)]BIS[N-2-THIAZOLYLBENZAMIDE]'>XV6</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1qbr| PDB=1qbr | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1qbr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1qbr OCA], [http://www.ebi.ac.uk/pdbsum/1qbr PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1qbr RCSB]</span>
+
-
}}
+
'''HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY'''
'''HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY'''
Line 28: Line 25:
[[Category: Ala, P.]]
[[Category: Ala, P.]]
[[Category: Chang, C H.]]
[[Category: Chang, C H.]]
-
[[Category: aspartyl protease]]
+
[[Category: Aspartyl protease]]
-
[[Category: hydrolase (acid proteinase)]]
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 06:06:33 2008''
-
 
+
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 23:11:33 2008''
+

Revision as of 03:06, 3 May 2008

Template:STRUCTURE 1qbr

HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY


Overview

Cyclic urea amides, a novel series of HIV-1 protease (HIV PR) inhibitors, have increased activity against drug-resistant mutants of the HIV PR. The design strategy for these inhibitors is based on the hypotheses that (i) the hydrogen-bonding interactions between the inhibitor and the protease backbone will remain constant for wild-type and mutant enzymes and (ii) inhibitors which are capable of forming many nonbonded interactions, distributed throughout the active site, will experience a lower percent change in binding energy as a result of mutation in the target enzyme than those that form fewer interactions by partial occupation of the active site. The cyclic urea amide, SD146, forms 14 hydrogen bonds and 191 van der Waals contacts to HIV PR. SD146 is a very potent antiviral agent (IC90 = 5.1 nM) against wild-type HIV and maintains the same or improved level of high potency against a range of mutant strains of HIV with resistance to a wide variety of HIV protease inhibitors.

About this Structure

1QBR is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV., Jadhav PK, Ala P, Woerner FJ, Chang CH, Garber SS, Anton ED, Bacheler LT, J Med Chem. 1997 Jan 17;40(2):181-91. PMID:9003516 Page seeded by OCA on Sat May 3 06:06:33 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools